Stocks and Investing Stocks and Investing
Wed, January 13, 2021
Tue, January 12, 2021
Mon, January 11, 2021
Sun, January 10, 2021
Fri, January 8, 2021

Joseph Schwartz Maintained (SRPT) at Buy with Decreased Target to $125 on, Jan 8th, 2021


Published on 2024-10-27 15:10:07 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Decreased Target from $197 to $125 on, Jan 8th, 2021.

Joseph has made no other calls on SRPT in the last 4 months.



There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020